We seek to purchase two TEG6S systems from haemonetics. These instruments allow a comprehensive assessment of blood coagulation parameters. This system generates data, including breakdown of blood clots, that other systems cannot perform.

The University of New Mexico Purchasing Department is pursuing a sole-source purchase of two TEG6S thromboelastography systems from Haemonetics Corporation, with a 30-day public posting period ending October 25, 2026. The sole-source justification rests on proprietary technology: TEG is the only system demonstrated in peer-reviewed literature to measure clot breakdown in rodent trauma models, a critical capability that competing systems such as ROTEM (Werfen) do not provide in rodent studies.

The scope is two TEG6S instruments for the Department of Cell Biology & Physiology to support trauma research involving rat models and assessment of blood coagulation parameters, including clotting time, kinetics of clot formation, maximum clot strength, and clot breakdown. The systems will enable simultaneous experimentation by multiple graduate students.

The contract value is $71,800 for purchase from Haemonetics Corporation at 125 Summer Street, Boston, Massachusetts. The requisition number is 221505987. The requestor is Jack Barry, Accountant II in the Department of Cell Biology & Physiology. Due diligence included literature review and consultation with trauma researchers at the Shock Society meeting; no alternative vendors manufacture comparable thromboelastography systems capable of the required rodent-model measurements.